BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer
Clinical trial NCT06462001 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06462001
- Sponsor
- Nottingham University Hospitals NHS Trust
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-10
- Primary completion
- 2026-12-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.